Rethinking furosemide use for infants with bronchopulmonary dysplasia

Jeffrey L Segar1

  • 1Division of Neonatology, Departments of Pediatrics and Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Pediatric Pulmonology
|March 17, 2020
PubMed

Insights

Diuretics like furosemide are used for infants with bronchopulmonary dysplasia (BPD), but long-term benefits lack prospective data. Understanding furosemide

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Pharmacology

Background:

  • Diuretics, specifically furosemide, are frequently used in infants with bronchopulmonary dysplasia (BPD) to enhance respiratory outcomes.
  • The long-term efficacy and safety of diuretic use in BPD remain incompletely understood, lacking robust prospective data.
  • While adverse effects of furosemide are recognized, a comprehensive understanding of its impact on infant pathophysiology is needed.

Purpose of the Study:

  • To highlight the common use of diuretics in infants with BPD.
  • To emphasize the need for a deeper understanding of furosemide's effects.
  • To encourage clinicians to consider potential complications of furosemide administration.

Main Methods:

  • Review of existing literature on diuretic use in BPD.
  • Analysis of known pathophysiological impacts of furosemide.
  • Discussion of implications for clinical practice.

Main Results:

  • Prospective data on long-term benefits of diuretics in BPD are absent.
  • Furosemide has known adverse effects, but its full impact requires further investigation.
  • Understanding the effects on sodium metabolism and cardiopulmonary physiology is crucial.

Conclusions:

  • Furosemide likely plays a role in managing BPD in infants.
  • Clinicians should be aware of and monitor for potential complications.
  • Further research is required to elucidate the complex effects of diuretics in BPD.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
156
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
185
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
362
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
164
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
737
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
222